- Clear All
- Remove theAVMA Newsfilter AVMA News
- Remove theBlog Postfilter Blog Post
- Remove theBasic pagefilter Basic page
- Remove theDrugs & vaccinesfilter Drugs & vaccines
- Remove theContinuing educationfilter Continuing education
- Remove theProduction medicinefilter Production medicine
- Remove theHuman-animal interactionsfilter Human-animal interactions
AVMA news
FDA CVM lays out innovation plan for new animal, veterinary products
Leaders with the Food and Drug Administration’s Center for Veterinary Medicine recently outlined the agency’s plan to support the development of safe…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
Addressing global inequities in access to essential medicines
The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability…
Animal Medicinal Drug Use Clarification Act (AMDUCA)
Information for veterinarians on use of the Animal Medicinal Drug Use Clarification Act (AMDUCA). Use with our interactive Extralabel Drug Use (ELDU)…
AVMA news
Artificial intelligence in veterinary medicine: What are the ethical and legal implications?
AVMA Axon recently debuted the webinar "Do No Harm: Ethical and Legal Implications of A.I." by Dr. Dr. Eli Cohen, a clinical professor of diagnostic…
blog
Farm bill delivers victory for veterinary medicine
The nation’s new farm bill creates critical programs to improve animal health and enhance the nation’s ability to prevent and respond to animal…
AVMA news
Convention sessions, statement touch on environmental impact of veterinary medicine
Speakers at AVMA Convention 2023 will talk about the impacts of climate change and how environmental sustainability is an increasingly important topic…
blog
Amoxicillin: Will a human drug shortage affect veterinarians?
A shortage of some amoxicillin products used in human medicine could affect veterinarians who use the drugs in an extra-label manner. No shortage of…
Compounding guidance for veterinarians
Learn about the regulatory parameters, quality control assurance, and practice considerations when using compounded products in veterinary medicine.
Cannabis: FAQs for veterinarians
Get answers to frequently asked questions about the regulatory status of cannabis, cannabis-derived, and cannabis-related products in veterinary…
AVMA news
WVC features AVMA sessions, research results
The AVMA offered sessions at the 2023 WVC Annual Conference as part of a year-old partnership with Viticus Group, the organization that hosts WVC.…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
AVMA news
FDA issues warnings over CBD for animals
Food and Drug Administration officials warned four companies that they were illegally marketing cannabidiol products for animal use.
AVMA news
Organizations warn against hemp in pet food, livestock feed
Seventeen organizations sent a joint letter that encourages agriculture and state government leaders to wait for results of safety studies before…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
Facing shortage, FDA CVM allows temporary imports of non-FDA approved drug for cattle
A national shortage of an important cattle reproduction drug has prompted the Food and Drug Administration to allow a similar but unapproved product…
AVMA news
FDA warns that topical drug for humans can be deadly to pets
As of September, the Food and Drug Administration had received 14 reports involving 20 dogs that had been accidentally exposed to topical…
AVMA news
Home delivery, autoship important offerings for veterinary clients
A recent survey from Brakke Consulting looked at consumer preferences and behaviors in pet medicine purchasing, customer satisfaction with different…
FAQs about extralabel drug use
See answers to common questions about extra-label drug use by veterinarians and the Animal Medicinal Drug Use Clarification Act.
AVMA news
USDA awards $3.2M in 2022 to support rural veterinary services
A project at Michigan State University to train veterinary students and practicing veterinarians in honeybee medicine was among 20 recipients of a…
AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
AVMA news
Summit addresses rise of antiparasitic resistance
Preventing parasiticide resistance in veterinary medicine is the theme of the 2022 Global Health Summit, which will be held Monday, Aug. 1, during…
Antimicrobial use and resistance: AVMA policies
Explore AVMA policies related to antimicrobial use in veterinary medicine, including guidelines on judicious therapeutic use, the definition of…
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
blog
June webinars: Cannabis use and the state of the equine profession
Cannabis is becoming increasingly available for human recreational and medical use. Should veterinary practices monitor staff use of marijuana and…